"Pseudomonas Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections with bacteria of the genus PSEUDOMONAS.
| Descriptor ID |
D011552
|
| MeSH Number(s) |
C01.252.400.739
|
| Concept/Terms |
Pseudomonas Infections- Pseudomonas Infections
- Infections, Pseudomonas
- Infection, Pseudomonas
- Pseudomonas Infection
|
Below are MeSH descriptors whose meaning is more general than "Pseudomonas Infections".
Below are MeSH descriptors whose meaning is more specific than "Pseudomonas Infections".
This graph shows the total number of publications written about "Pseudomonas Infections" by people in this website by year, and whether "Pseudomonas Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 3 | 0 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 5 | 1 | 6 |
| 2017 | 50 | 19 | 69 |
| 2018 | 45 | 15 | 60 |
| 2019 | 19 | 4 | 23 |
| 2020 | 5 | 3 | 8 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Pseudomonas Infections" by people in Profiles.
-
Acute SARS-CoV-2 infection is associated with an increased abundance of bacterial pathogens, including Pseudomonas aeruginosa in the nose. Cell Rep. 2021 08 31; 36(9):109637.
-
Emergence of Resistance to Novel Cephalosporin-ß-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump. Antimicrob Agents Chemother. 2021 07 16; 65(8):e0008921.
-
Integrated evaluation of lung disease in single animals. PLoS One. 2021; 16(7):e0246270.
-
The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies. Front Cell Infect Microbiol. 2021; 11:665759.
-
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages. FASEB J. 2021 04; 35(4):e21441.
-
Persistent Bacterial Coinfection of a COVID-19 Patient Caused by a Genetically Adapted Pseudomonas aeruginosa Chronic Colonizer. Front Cell Infect Microbiol. 2021; 11:641920.
-
Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. Elife. 2020 12 17; 9.
-
The Goldman-Fox syndrome: Treating and preventing green pseudomonas nails in the era of COVID-19. Dermatol Ther. 2021 Jan; 34(1):e14624.
-
Severe cortical damage associated with COVID-19 case report. Seizure. 2021 Jan; 84:66-68.
-
New guidelines to treat bacterial infections. Lancet Infect Dis. 2020 11; 20(11):1239.